Infectious Disease - HIV/Immunodeficiency News & Articles

181 Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children JAMA, May 1, 2013    Clinical Article

182 Dynamical models of biomarkers and clinical progression for personalized medicine: The HIV context Advanced Drug Delivery Reviews, May 1, 2013    Clinical Article

183 Meta-analyses of fertility desires of people living with HIV Full Text BMC Public Health, May 1, 2013    Evidence Based Medicine

184 CD4 decline is associated with increased risk of cardiovascular disease, cancer and death in virally suppressed HIV patients Clinical Infectious Diseases, May 1, 2013    Review Article

185 Natural history of anal versus oral HPV infection in HIV-infected men and women The Journal of Infectious Diseases, May 1, 2013    Clinical Article

186 Evaluation of HIV and HAART on the natural history of HPV infection and cervical cytopathology in HIV-positive and high risk HIV-negative women The Journal of Infectious Diseases, May 1, 2013    Clinical Article

187 Will it be possible to live without antiretroviral therapy Current Opinion in HIV and AIDS, May 1, 2013    Clinical Article

188 Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration AIDS, May 1, 2013    Review Article

189 Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naive infected individuals Infection, May 1, 2013    Review Article

190 Autonomic dysfunction is common in HIV and associated with distal symmetric polyneuropathy Journal of NeuroVirology, May 1, 2013    Clinical Article

191 An ancestral HIV-2/simian immunodeficiency virus peptide with potent HIV-1 and HIV-2 fusion inhibitor activity AIDS, May 1, 2013    Review Article

192 Outcomes After Acute Myocardial Infarction in HIV-Infected Patients Circulation, May 1, 2013    Clinical Article

193 Overcoming pharmacologic sanctuaries Current Opinion in HIV and AIDS, April 30, 2013    Clinical Article

194 Prevalent and Incident Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men Engaged in Primary Care in a Boston Community Health Center Clinical Infectious Diseases, April 30, 2013    Clinical Article

195 Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death Clinical Infectious Diseases, April 30, 2013    Clinical Article

196 Herpes Simplex Virus Type 2 Co-infection Does Not Accelerate CD4 Count Decline in Untreated HIV Infection Clinical Infectious Diseases, April 30, 2013    Clinical Article

197 Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy Clinical Infectious Diseases, April 30, 2013    Clinical Article

198 Codon pairs of the HIV-1 vif gene correlate with CD4+ T cell count Full Text BMC Infectious Diseases, April 30, 2013    Review Article    Clinical Article

199 Microbial Translocation Induces an Intense Proinflammatory Response in Patients With Visceral Leishmaniasis and HIV Type 1 Coinfection The Journal of Infectious Diseases, April 30, 2013    Clinical Article

200 Development of a fluorescence-based HIV-1 integrase DNA binding assay for identification of novel HIV-1 integrase inhibitors Antiviral Research , April 30, 2013    Clinical Article

1 A Conceptual Framework for Understanding Chronic Pain in Patients with HIV Pain Practice, April 5, 2013

2 The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies PLoS Medicine, March 15, 2013    Free full text    Evidence Based Medicine

3 Is Frequent CD4+ T-Lymphocyte Count Monitoring Necessary for Persons With Counts >=300 Cells/{micro}L and HIV-1 Suppression Clinical Infectious Diseases, April 11, 2013

4 Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy Journal of Medical Economics , April 12, 2013

5 Contribution of genetic background, traditional risk factors and HIV-related factors to coronary artery disease events in HIV-positive persons Clinical Infectious Diseases, April 1, 2013

6 A Pill for HIV Prevention: Deja Vu All Over Again Clinical Infectious Diseases, March 28, 2013

7 Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients: Final 5-Year Results From STARTMRK Journal of Acquired Immune Deficiency Syndromes, April 16, 2013

8 SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitibine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen Clinical Infectious Diseases, April 2, 2013

9 Faith-Based HIV Prevention and Counseling Programs: Findings from the Cincinnati Census of Religious Congregations AIDS and Behavior, April 10, 2013

10 Effects of Smoking on Non-AIDS-Related Morbidity in HIV-Infected Patients Clinical Infectious Diseases, April 29, 2013

11 Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013

12 Hcv clearance from saliva of hiv-hcv coinfected patients on treatment with interferon plus ribavirin Oral Diseases , April 15, 2013    Evidence Based Medicine

13 CD4 Count Slope and Mortality in HIV-Infected Patients on Antiretroviral Therapy: Multicohort Analysis From South Africa Journal of Acquired Immune Deficiency Syndromes, April 12, 2013    Review Article

14 A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection: Analysis of Week 96 Results Journal of Acquired Immune Deficiency Syndromes, April 17, 2013

15 Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001-2009 Clinical Infectious Diseases, February 26, 2013

16 Monocyte and Myeloid Dendritic Cell Activation Occurs Throughout HIV Type 2 Infection, an Attenuated Form of HIV Disease The Journal of Infectious Diseases, April 12, 2013

17 Rilpivirine vs. efavirenz in HIV-1 patients with baseline viral load 100,000 copies/ml or less: week 48 phase III analysis AIDS, March 21, 2013

18 Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis The Lancet Infectious Diseases, April 18, 2013

19 Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs The Lancet, March 29, 2013

20 Immune control of HIV-1 reservoirs Current Opinion in HIV and AIDS, April 23, 2013